Jeremy G. Richman
Boehringer Ingelheim (Brazil)(BR)Boehringer Ingelheim (France)(FR)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Diabetes Treatment and Management, Neuropeptides and Animal Physiology, Neurotransmitter Receptor Influence on Behavior, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G(2005)640 cited
- → Langerhans Cells Release Prostaglandin D2 in Response to Nicotinic Acid(2006)188 cited
- → Agonist-regulated Interaction between α2-Adrenergic Receptors and Spinophilin(2001)123 cited
- → Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors(2007)99 cited
- The Modern Fault Dictionary.(1985)
- → 3-(1H-Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice(2008)93 cited
- → The ζ Isoform of 14-3-3 Proteins Interacts with the Third Intracellular Loop of Different α2-Adrenergic Receptor Subtypes(1999)92 cited